André, Marc

Aurer, Igor

Burkhardt, Birgit

Buske, Christian

Bödör, Csaba

Campo, Elias

Chapuy, Bjoern

Davies, Andrew

de Leval, Laurence

Dollores Caballero, Maria

Doorduijn, Jeanette

Dreyling, Martin

Federico, Massimo

Ferreri, Andrés

Fox, Christopher

Gaulard, Philippe

Gay, Francesca

Ghia, Paolo

Goldschmidt, Hartmut

Gribben, John

Grønbæk, Kirsten

Gökbuget, Nicola

Jerkeman, Mats

Kersten, Marie-Jose

Kiesewetter, Barbara

Landman-Parker, Judith

Le Gouill, Steven

Lenz, Georg

Leppä, Sirpa

López Guillermo, Armando

Macintyre, Elizabeth

Mantega, Maria Victoria Mateos

Maria Ribera, José

Moreau, Philippe

Morel, Pierre

Moreno, Carol

Nadel, Bertrand

Okosun, Jessica

Owen, Roger

Pospisilova, Sarka

Pott, Christiane

Robak, Tadeusz

Salles, Gilles

Spina, Michelle

Stamatopoulos, Kostas

Stary, Jan

Stilgenbauer, Stephan

Tarte, Karin

Tedeschi, Allessandra

Thieblemont, Catherine

Tilly, Hervé

Trappe, Ralf Ulrich

Trümper, Lorenz H.

Universitat Autònoma de Barcelona

Zweegman, Sonja

HemaSphere

English

PubMed

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy

De Leval, Laurence

Kersten, Marie Jose

Lopez-Guillermo, Armando

NARCIS 

The EHA Research Roadmap: Malignant Lymphoid Diseases

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy. © 2022 Wolters Kluwer Health. All rights reserved

Ribera, Josep Maria

Caballero, Maria Dolores

Campo, Elías

Leval, Laurence de

Kiesewetter, Barbara3

Gouill, Steven le

Mateos Mantega, Maria Victoria

Diposit Digital de la Universitat de Barcelona

Veterinary medicine - Repository of PHD, master's thesis

Andre, Marc

Tilly, Herve

Ferreri, Andres

Ribera, Jose Maria

Bödür, Csaba

Caballero, MariaDollores

Chapuy, Björn

Gronbaek, Kirsten

Open Access LMU

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy.</p

EUR Research Repository

The EHA Research Roadmap:Malignant Lymphoid Diseases

PubMed Central

University of Zagreb Repository

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy

The EHA Research Roadmap : Malignant Lymphoid Diseases

Abstract

Similar works

Full text

Available Versions

NARCIS

Diposit Digital de la Universitat de Barcelona

Veterinary medicine - Repository of PHD, master's thesis

Open Access LMU

EUR Research Repository

PubMed Central

University of Zagreb Repository

DIAL UCLouvain

NARCIS

Copenhagen University Research Information System